Filing Details
- Accession Number:
- 0001567619-20-016894
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-18 20:00:44
- Reporting Period:
- 2020-09-17
- Accepted Time:
- 2020-09-18 20:00:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1628171 | Revolution Medicines Inc. | RVMD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1462808 | Michael Stephen Kelsey | C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-17 | 11,363 | $31.03 | 251,966 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-18 | 637 | $31.03 | 251,329 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- The transaction was executed in multiple trades in prices ranging from $31.00 to $31.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.